Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases.
Wernicke AG, Yondorf MZ, Peng L, Trichter S, Nedialkova L, Sabbas A, Kulidzhanov F, Parashar B, Nori D, Clifford Chao KS, Christos P, Kovanlikaya I, Pannullo S, Boockvar JA, Stieg PE, Schwartz TH. Wernicke AG, et al. Among authors: christos p. J Neurosurg. 2014 Aug;121(2):338-48. doi: 10.3171/2014.3.JNS131140. Epub 2014 May 2. J Neurosurg. 2014. PMID: 24785322 Free PMC article. Clinical Trial.
Prospective study validating inter- and intraobserver variability of tissue compliance meter in breast tissue of healthy volunteers: potential implications for patients with radiation-induced fibrosis of the breast.
Wernicke AG, Parashar B, Kulidzhanov F, Riley L, Christos PJ, Fischer A, Nori D, Chao KS. Wernicke AG, et al. Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):39-46. doi: 10.1016/j.ijrobp.2010.01.064. Epub 2010 Apr 13. Int J Radiat Oncol Biol Phys. 2011. PMID: 20395064 Free PMC article.
A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.
Wernicke AG, Goodman RL, Turner BC, Komarnicky LT, Curran WJ, Christos PJ, Khan I, Vandris K, Parashar B, Nori D, Chao KS. Wernicke AG, et al. Breast Cancer Res Treat. 2011 Feb;125(3):893-902. doi: 10.1007/s10549-010-1167-6. Epub 2010 Sep 19. Breast Cancer Res Treat. 2011. PMID: 20853176 Free PMC article.
Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.
Boockvar JA, Tsiouris AJ, Hofstetter CP, Kovanlikaya I, Fralin S, Kesavabhotla K, Seedial SM, Pannullo SC, Schwartz TH, Stieg P, Zimmerman RD, Knopman J, Scheff RJ, Christos P, Vallabhajosula S, Riina HA. Boockvar JA, et al. Among authors: christos p. J Neurosurg. 2011 Mar;114(3):624-32. doi: 10.3171/2010.9.JNS101223. Epub 2010 Oct 22. J Neurosurg. 2011. PMID: 20964595 Free PMC article. Clinical Trial.
Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival.
Burkhardt JK, Riina H, Shin BJ, Christos P, Kesavabhotla K, Hofstetter CP, Tsiouris AJ, Boockvar JA. Burkhardt JK, et al. Among authors: christos p. World Neurosurg. 2012 Jan;77(1):130-4. doi: 10.1016/j.wneu.2011.05.056. Epub 2011 Nov 21. World Neurosurg. 2012. PMID: 22405392 Free PMC article. Clinical Trial.
Is there a cause-specific survival benefit of postmastectomy radiation therapy in women younger than age 50 with T3N0 invasive breast cancer? A SEER database analysis: outcomes by receptor status/race/age: analysis using the NCI Surveillance, Epidemiology, and End Results (SEER) database.
Yan W, Christos P, Nori D, Chao KS, Ravi A. Yan W, et al. Among authors: christos p. Am J Clin Oncol. 2013 Dec;36(6):552-7. doi: 10.1097/COC.0b013e31825d529b. Am J Clin Oncol. 2013. PMID: 22868241
371 results